The kit arrives in the mail. You swab the inside of your cheek and mail it back. Two weeks later, the company emails you a report. You are told you have a 2% risk of getting COVID-19 and a 5%...
What should public health bodies do in the absence of data? And, even more importantly, what should the people left to make an important health decision do when no data is available?...
Imagine a wall-mounted device that continuously scans the air and alerts you to the presence of the coronavirus. This would be a boon for commercial buildings, hospitals, schools, and mass transit...
On March 11, 2020, the World Health Organization announced that COVID-19 could be “characterized as a pandemic,” meaning that this new disease was now spreading all over the world. One day, we will...
The race is on! Pharmaceutical companies and assorted academic researchers around the world are engaged in the quest for the current version of the Holy Grail, a vaccine against the SARS-CoV-2...
On this week’s “COVID-19 and More: Conversations with the McGill Office for Science and Society”, Joe Schwarcz Jonathan Jarry, Emily Shore, and guest Dr. Debbie Schwarcz Gonshor discuss the latest...
Technology is imperfect. Anyone who’s ever used a computer knows this. You search for a file that you know to be on your hard drive and somehow the search function just cannot find it. If computers...
Whatever the end result may be, the attack starts with the virus invading cells in the lining of the nose and throat. Here the virus can latch on to a protein known as “angiotensin converting...
RSS